Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
Cholangiocarcinoma is a group of malignancies with poor prognosis. Treatments for the management of advanced-stage cholangiocarcinoma are limited, and the 5-year survival rate is estimated to be approximately 5–15%, considering all tumor stages. There is a significant unmet need for effective new tr...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/82767877420544568ea0e262ab6c2d4e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|